Milton Essex S. A. of Warschau at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers Trader OEM

Milton Essex S. A.

Ul. Woronicza 31/348, 02-640 Warschau
Telephone +48 510 738-710
Fax +48 22 510070562

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

Hall map

MEDICA 2021 hall map (Hall 9): stand E29

Fairground map

MEDICA 2021 fairground map: Hall 9


Jacek Stępień (PhD, Assist. Prof.)

Chairman of the Supervisory Board

+48 510 099 582


Radosław Solan

Vice President of the Management Board, Chief Financial Officer

+48 695 738 303


Iwona Kaczynska-Stepien

President of the board

+48 510 099 581


Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Visit us

Hall 9 / E29

16 Nov 2021


11:00 - 12:00

SkinSens Pilot Program

More Less

Our range of products

Product categories

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.01  Diagnostics
  • 01.01.13  Other diagnostic equipment

Other diagnostic equipment

  • 01  Imaging and diagnostics / medical equipment and devices
  • 01.02  Imaging supplies
  • 01.02.05  Other imaging equipment
  • 06  IT systems and IT solutions
  • 06.04  eHealth, telemedicine / telematics / telemetry

eHealth, telemedicine / telematics / telemetry

Our products

Product category: Other imaging equipment

Automation by SkinSens™

The Artificial Intelligence SkinLogic™ will relieve physicians from the necessity of epidermal symptom’s evaluation by introducing a new type of functional biophysical markers.

Our Intelligent System is designed to support and accelerate allergen identification. By introducing a new type of functional biophysical markers our Artificial Intelligence SkinLogic™ will relieve physicians from the necessity of epidermal symptom’s evaluation. Digitization and objectifying the reading of skin tests allow to transmit the results within telemedicine systems using a specially developed plug-in fully compatible with the standard DICOM browser.


• A new approach to allergy diagnostics - SkinSens™ System is the latest generation scanner equipped with an optoelectronic multispectral imaging head, developed by the research consortium R&D ‘FOTONICA’ together with engineers from the Institute of Optoelectronics of the renowned Military University of Technology.

• Speed and precision – ‘in vivo’ allergy diagnostics has become fast and precise thanks to the additional use of deep learning - Artificial Intelligence SkinLogic™. This allows for full automation of the evaluation of skin test results with much higher accuracy and repeatability.

• Digitisation - provides the possibility of performing skin allergy tests and sending only digital results directly to a doctor's computer equipped with a standard DICOM browser. That simplifies and improves the work of an allergy clinic and speeds up the process of identifying allergens causing allergies.

• Digital dermatoscope function - The SkinSens™ system provides an additional dermatoscopic option - viewing digital images of allergic skin reactions in visible light. It is with filtration and separately in far infrared (LWIR), as well as displaying hybrid fusion images. That increases diagnostic precision and ensures test results can be compared over time.


The benefits of digital allergy skin tests reading by Skinsens™

are focused on automation & improved diagnostic quality.

SkinSens™ helps to bridge the diagnostic gap resulting from rapidly growing demand for allergy tests in relation to the insufficient number of allergists.

The acceleration of instrumental diagnosis makes possible to offer effective desensitization immunotherapy during a single consultation.

SkinSens™ creates a new quality for the in vivo allergy diagnostics and moving it into the world of digital medicine of the 21st Century.

In the Europe and USA approx. 20 mln allergy tests are performed every year.



Effectiveness proven in clinical trials

The results of clinical trials conducted in 2018-19 at the Military Medical Institute under supervision of Prof. K. Jahnz-Różyk showed the great diagnostic potential of Artificial Intelligence SkinLogic™ and the new method of assessing the results of allergic skin tests, valuated by the AUC Index that reached 0,987 and showed a very promising outcome on a global scale.

More Less

Product category: Other diagnostic equipment

SkinSens ™

The solution is to automate the reading of skin allergy tests. Our SkinSens ™ system with the HYBRID II ™ transducer for hyperspectral imaging brings a new dimension to allergology by:
  • the use of a unique sensor system,
  • the use of Artificial Intelligence accurately estimating the severity of allergies
  • reducing the risk of allergy misdiagnosis:
    replacing the eye measurement, performed with a ruler or a measure, with an algorithmic evaluation based on the measured physical values - inflammatory field size and temperature – meeting the requirements of Evidence-Based Medicine.
The SkinSens ™ System is 100% compatible with all skin test kits available on the market, both for the “Prick Tests” and “Patch Tests”.

More Less

Product category: Other imaging equipment


FACE-COV will probably be the first registered medical device in the world that allows remote temperature measurement from a long distance. The medical characteristics of the device will ensure high quality of measurement and avoiding errors. Application at airports or stations, where people detained due to incorrectly measured temperature may miss the plane or train and charge the operator with compensation, will help avoiding consequences .

More Less

About us

Company portrait


MILTON ESSEX SA is a med-tech public company listed on the NewConnect Market of the Warsaw Stock Exchange, which specializes in development of advanced medical imaging systems equipped with Artificial Intelligence dedicated for automated noninvasive diagnostics of skin tissue on basis of multispectral scanning (including far infrared spectrum). We implement infrared imaging technology thanks to close engineering cooperation in a frame of a joint research Consortium "FOTONICA" with the Institute of Optoelectronics of the Military University of Technology - a leading European center for laser & optronics technology. Intelligent digital systems for multispectral hybrid imaging are extremely complex diagnostic tools which place MILTON ESSEX SA in the world's premier league of med-equipment manufacturers focusing on skin diseases/allergies. 

 Automation of allergy diagnostics

The basic instruments that support the physician in the daily diagnosis of skin diseases have basically remained unchanged for more than 70 years. They are almost without exception based on optical technique, i.e. a more or less precise magnifying glass that allows viewing lesions in visible light at high magnification.Only in recent years, optical dermatoscopy has been supported by computer image analysis, allowing further comparison with other cases collected in digital libraries. However, the best computer systems cannot overcome the barrier of relying in skin diagnostics on symptomatology, i.e. assessment of morphology of the examined lesion in visible light (based on shape, pigmentation, contour, etc.). Such approach, which is focusing only on the epidermally visible symptoms rather on scientifically proven markers, cannot be longer accepted due to requirements of EBM (Evidence-Based Medicine). Our innovative methodology is characterized by application of machine vision in the spectral range that allows imaging of subepidermally localized lesions, as in the case of cutaneous allergic reaction and the accompanying dermothermic effect (DTE). This technique also could be easily adopted for early automated detection of skin lesions with a high risk of neoplastic transformation, which significantly expands the capabilities of modern dermatoscopes.

SkinLogic™ Artificial Intelligence applied to our diagnostic systems represents a real breakthrough in the automated detection of skin pathology markers.The results of clinical trials conducted in 2018-19 at the Military Medical Institute under the direction of Prof. K. Jahnz-Rózyk showed the high diagnostic potential of the new method of assessing the results of allergic skin tests described by the AUC index, which reached almost 99%, and constitutes a very promising result on a global scale.